TargImmune Therapeutics ^Company

TargImmune Therapeutics is a biotech company based in Switzerland that specializes in developing targeted onco-immunotherapies to combat cancer. They use the CTPIC technology platform, which involves a non-viral vector to destroy cancer cells that over-express specific receptors while also triggering an immune response against the cancer cells. The company's goal is to enhance the survival rate of cancer patients.